Theranostics · 2017 · 75 citations · 47 references
PharmacyDermatologyPharmaceuticsDrug DeliveryInflammationNanoparticle Drug DeliveryDrug EncapsulationNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsProtein DeliveryDrug Delivery NanocarriersHydrogel EncapsulationNanocarrier StabilityNanogelsProtein Delivery NanoparticlesProtein EncapsulationStratum Corneum StructureThermoresponsive Gels
. Nevertheless, there are indications protein delivery may be possible in barrier deficient skin, a condition found in several inflammatory skin diseases such as psoriasis, using novel nanocarrier systems. METHODS: encapsulation of protein during assembly, something that holds great promise for easy manufacture and storage. Topical application of ETR loaded tNGs to inflammatory skin equivalents or tape striped human skin resulted in efficient ETR delivery throughout the SC and into the viable epidermis that correlated with clear anti-inflammatory effects. Notably, effective ETR delivery depended on temperature triggered release following topical application. CONCLUSION: Together these results indicate tNGs hold promise as a biocompatible and easy to manufacture vehicle for stable protein encapsulation and topical delivery into barrier-deficient skin.
47
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Philip J. Mease, Bernard S. Goffe, James M. Metz et al. · The Lancet · 2000 · 1.5K citations
Etanercept Therapy in Rheumatoid Arthritis
Larry W. Moreland · Annals of Internal Medicine · 1999 · 1.4K citations